Martine Rothblatt
2021
In 2021, Martine Rothblatt earned a total compensation of $3.5M as Chairperson and Chief Executive Officer at United Therapeutics, a 27% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $2,132,813 |
|---|---|
| Salary | $1,367,858 |
| Other | $10,400 |
| Total | $3,511,071 |
Rothblatt received $2.1M in non-equity incentive plan, accounting for 61% of the total pay in 2021.
Rothblatt also received $1.4M in salary and $10.4K in other compensation.
Rankings
In 2021, Martine Rothblatt's compensation ranked 3,816th out of 12,397 executives tracked by ExecPay. In other words, Rothblatt earned more than 69.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,816 out of 12,397 | 69th |
Division Manufacturing | 1,559 out of 5,492 | 72nd |
Major group Chemicals And Allied Products | 633 out of 2,367 | 73rd |
Industry group Drugs | 562 out of 2,090 | 73rd |
Industry Pharmaceutical Preparations | 392 out of 1,537 | 75th |
Pay ratio
| Martine Rothblatt's Pay | $3,511,071 |
|---|---|
| Median Employee's Pay | $189,023 |
| Pay Ratio | 19to 1 |
In 2021, the annual total compensation of Martine Rothblatt was $3,511,071.
The annual total compensation of the median employee at United Therapeutics was $189,023.
The ratio of Martine Rothblatt's pay to the pay of median employee was therefore 19 to one.
Source: SEC filing on April 29, 2022.
Rothblatt's colleagues
We found three more compensation records of executives who worked with Martine Rothblatt at United Therapeutics in 2021.